A Randomized, Placebo -Controlled, Double-Blind, Phase 4 Study To Compare The Effect Of Celecoxib 100 Mg BID, Loxoprofen 60 Mg TID And Placebo On The Gastroduodenal Mucosa In Healthy Subjects.

Trial Profile

A Randomized, Placebo -Controlled, Double-Blind, Phase 4 Study To Compare The Effect Of Celecoxib 100 Mg BID, Loxoprofen 60 Mg TID And Placebo On The Gastroduodenal Mucosa In Healthy Subjects.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2012

At a glance

  • Drugs Celecoxib; Loxoprofen
  • Indications Pain; Rheumatic disorders
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 10 May 2011 Results presented at the Digestive Disease Week 2011.
    • 20 May 2010 Actual patient number (190) added as reported by ClinicalTrials.gov.
    • 20 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top